Skip to main content
Caplight Logo









Microbion Corporation

Microbion Corporation

Private
Bozeman, MontanaHealthcare & Life Scienceshttps://microbioncorp.com/

Last Round

Grant

Jun 7, 2022

Total Funding Raised

$55.08M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Microbion Corporation is a clinical-stage pharmaceutical company that develops a novel class of compounds for the treatment of difficult-to-treat infections, including chronic and antibiotic-resistant infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

antibiotic resistancepravibismanesuperbugsbiofilm eradicationanti-infective drugsanti-biofilmdiabetic foot ulcer treatmentorthopedic implant infectionclinical-stage pharmachronic infection treatmentfirst-in-class drugdrug-resistant pathogenscystic fibrosis infectionnon-tuberculous mycobacteriaNTM infectionnon-dilutive funding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Microbion Corporation Comparables

Compare Microbion Corporation with similar companies based on industry and business-model similarity.

Microbion Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Recce Pharmaceuticals Ltd
83%
NovaBiotics Ltd
79%
BiomX Inc.
78%

Microbion Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 7, 2022
VC RoundAug 20, 2021
VC RoundMar 1, 2021
GrantFeb 22, 2021
StrategicJan 12, 2021
Grant
May 28, 2020

Microbion Corporation Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 272% MoM, reaching 2.5K.

  • Nov 7, 2025

    Monthly visitors increased 239% MoM.

Microbion Corporation Filings

Explore SEC and related filing metadata, where available.

Microbion Corporation filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Microbion Corporation's valuation, stock price, and market status.

Is Microbion Corporation a public or private company?

Microbion Corporation is a private company.

What is the current stock price of Microbion Corporation?

Microbion Corporation is a private company with no public stock price. No recent secondary market data is available.

How much is Microbion Corporation worth (valuation)?

Valuation information for Microbion Corporation is not publicly available.

Can I buy Microbion Corporation stock?

Microbion Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Microbion Corporation's last funding round?

Microbion Corporation's most recent funding round was Grant on June 7, 2022.

Who are the main investors in Microbion Corporation?

Key investors in Microbion Corporation include GF Securities, Quark Venture.

Will Microbion Corporation IPO soon?

No public IPO plans have been announced for Microbion Corporation.

How can I track Microbion Corporation secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Microbion Corporation's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBozeman, Montana
Employee Range5
Year Founded2000
Last FundingJun 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?